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1. Introduction 
Attempts at nervous system electrical stimulation (a.k.a., brain stimulation, 
neurostimulation, electrical stimulation, neuromodulation, or deep brain stimulation (DBS)) 
have been made to treat drug-resistant forms of movement disorders and other conditions 
such as chronic pain, major depression, and more recently, seizure disorders (Theodore and 
Fisher 2004; Theodore 2005). Experimental results in some cases have been promising and 
DBS, a form of electrical stimulation, has been approved (2002) by the Food and Drug 
Administration (FDA) as a treatment for Parkinson’s Disease.  
Recent lab and clinical data also suggest that electrical brain stimulation in central and 
peripheral nervous system targets reduces seizure frequency in epileptic patients and in 
animal models of recurrent seizures (Cooper, Upton et al. 1982; Engbaek, Ostergaard et al. 
1989; Benabid, Pollak et al. 1991; Brusa, Pierantozzi et al. 2001; Benabid, Minotti et al. 2002; 
Vitek 2002; Lang, Kleiner-Fisman et al. 2003; Vonck, Boon et al. 2003; Benabid, Wallace et al. 
2005; Boon, Vonck et al. 2007; Velasco, Velasco et al. 2007; Arai, Yokochi et al. 2008; 
Montgomery and Gale 2008; Aybek, Lazeyras et al. 2009; Baumer, Hidding et al. 2009; 
Berweck 2009; Boon, Raedt et al. 2009; Rezai 2009). These findings may seem counter 
intuitive given the fact that electrical stimulation in the nervous system has been used in 
many cases to excite neurons, or to replace a lost function following injury. Nevertheless, 
electrical stimulation under certain conditions has been shown to reduce seizure activity. 
For example, in the peripheral nervous system, vagus nerve stimulation (VNS) has been 
performed in humans for many years (FDA approved 1997) where clinical studies show 
reductions in seizure frequency (Woodbury and Woodbury 1990; Vonck, De Herdt et al. 
2009). More recently electrical stimulation of the central nervous system has been attempted 
to treat epilepsy in both animals and humans where animal studies have varied in efficacy 
and human studies, although very promising, have not always been well designed or 
controlled. 
Neurostimulation for seizure control typically involves the stimulation of brain structures 
that can be conceptually divided into three groups. These include structures that are: 1) 
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directly involved in epileptic activity, such as the hippocampal formation, 2) white matter 
tracks, which are connected to epileptogenic regions, or 3) deep brain structures, such as the 
subthalamic nucleus.  
However, in spite of the fact that brain stimulation has been utilized in clinical settings in 
humans, no mechanism for neurostimulation has yet been substantiated with sufficient 
evidence. In addition, more work is needed to elucidate targets and electrical parameters for 
optimal delivery, such as stimulation frequency and mode, etc.  
This chapter will cover the key points of neurostimulation and also some of the unresolved 
aspects of neurostimulation in epilepsy, namely targets for stimulation, parameters of 
stimulation, and potential mechanisms associated with stimulation. It will primarily focus on 
aspects of CNS neuromodulation. It will conclude with interesting highlights from two clinical 
trials, both of which are currently ongoing and to date have shown positive results. Finally, 
some brief discussion will be made concerning future directions of neurostimulation. 
2. Targets for stimulation 
Electrical stimulation has been attempted in several regions of the brain and includes the 
hippocampal formation, cerebellum, caudate nucleus, centromedian thalamus, anterior 
thalamus, subthalamus, and neocortical regions, to name a few (Table 1). However, the best 
structures to stimulate and the most effective stimulation protocols to use in each target are 
still a matter of debate and are under investigation (Theodore and Fisher 2004). As 
mentioned above, these targets can be subdivided conceptually into several categories 
including: direct focal targets (ie., epileptogenic zone), deep brain nuclei, and white matter 
tracts.  
More specifically, one approach that has been taken with white matter tract stimulation is to 
stimulate a white matter tract that is connected to the majority of the neurons in the epileptic 
zone. For example, stimulation of the corpus callosum or the fornix has been accomplished 
with the hope that by applying supramaximal stimulation intensity to these tracts that 
epileptogenic activity can be completely blocked (a.k.a., overdrive stimulation) (Luders, Najm 
et al. 2004). The rationale for using supramaximal intensities is that at this level of intensity it 
appears unlikely to elicit additional epileptic seizures. Pilot animal studies thus far using 
bilateral stimulation of the fornix have been encouraging, but are limited in number.  
With regard to direct stimulation of the epileptic zone, cortical and hippocampal targets 
have been the most common targets explored thus far. In particular, hippocampal sclerosis 
is one of the most common forms of epilepsy where these patients are frequently not 
surgical candidates due to concerns about potential memory deficits following surgery. 
Therefore, it is hoped that electrical stimulation of the hippocampus might be developed as 
a viable therapeutic alternative for these individuals. To date, small clinical trials by Velasco 
et al. (Velasco, Velasco et al. 2000; Velasco, Velasco et al. 2000; Velasco, Velasco et al. 2007) 
have been performed and have showed promising results, however these studies were not 
double-blinded in design and so more work is needed in this area.  
Several deep brain structures have also been targeted. These include the caudate nucleus, 
the posterior hypothalamus, the thalamic nuclei, and the subthalamic nuclei. Among these 
targets, recent studies appear to favor the thalamic and subthalamic nuclei (STN). 
Interestingly, in the early 1980s the nigral control of epilepsy system (NCES) was described 
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(Iadarola and Gale 1982) where the STN seems to play major role in this system. Past studies 
indicated that abnormal activity in the STN was a main feature in the pathology of 
movement disorders. However, more recently the role of the STN in epilepsy has been 
investigated and targeted with DBS stimulation protocols.  
3. Parameters of stimulation 
There are a number of variables that are important to consider when attempting to 
understand the parameters associated with neurostimulation.  These include the basic 
physical properties and relationships such as energy sources, voltage, current, resistance, 
capacitance, and fields, etc. An exhaustive discussion of these properties and relationships is 
not the focus of this chapter and there are many excellent references that can be examined in 
this regard (see (Feyman, Leighton et al. 1977)). Our consideration will be qualitative for the 
most part. One fundamental relationship to briefly present in this context is of course, 
Ohm’s law, V = IR or R = V/I. In this relationship, resistance (R) measures the magnitude of 
voltage (V) across an element when passing the circuit current (I). We introduce this concept 
since neurons and glial cells of the brain have resistive properties. Similar to resistance we 
can think of another property, that of resistivity (ρ), which takes into account a current 
flowing through a cross-sectional area (such as a fiber tract). The reciprocal of resistivity or 
1/ρ is the conductivity (σ). It is often more intuitive to think in terms of conductivity when 
analyzing ion channel function in the nervous system. 
In addition, one needs to consider the location of the stimulation electrodes, the strength 
and duration of a stimulus, the geometry of the target being stimulated, and other electrical 
characteristics of the target tissue. When analyzing the geometry of potential nervous 
system targets, there are two shapes that are typically used as models, that is, a spherical cell 
and a cylindrical fiber. For a quantitative description of these models several resources are 
suggested for additional reading (Plonsey 2008). In actual biological systems, cells and 
tissues are considerably more complex than simple spheres or cylinders, but this geometry 
serves as a useful starting point for our discussion. 
For example, an external device such as a stimulator delivers current to the target cells and 
creates a rising transmembrane voltage, which at first is subthreshold (ie., a graded potential) 
when delivered at low intensities. In this simplistic model, the transmembrane potential will 
be nearly uniform at all points on the cell membrane and the entire membrane will respond in 
a similar manner. However, fibers are evaluated using stimuli placed in different locations 
along the length of the fiber and require additional considerations. Another perspective that is 
helpful is to think of action potentials propagating along a cylindrical nerve fiber, which has an 
excitable membrane. In this scenario, each patch of excitable membrane initiates the transfer of 
a packet of energy to adjacent patches of excitable membrane. Classic cable theory has been 
applied to nerve fibers to mathematically describe the propagation process (Plonsey 2008) 
more precisely. In addition, the reader is referred to standard neurophysiology texts (Kandel, 
Schwartz et al. 2000) that discuss the well documented permeability changes that involve 
sodium and potassium flux, etc. One other noteworthy point regarding geometry is that the 
orientation of nerve cells relative to the voltage field (ie., voltage gradient) is important since 
those cells in the direction of the voltage gradient will more likely be activated than those cells 
lying along an isopotential line. 
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In addition, neurostimulators are either monopolar or bipolar in configuration. 
Depending on which type is used will determine the current density around the electrode, 
how easily some cells are activated, and which population of cells is activated. In general, 
nerve cells that are nearer the electrode will more likely be stimulated.  However, axons 
will be stimulated at lower stimulation intensities than nerve cell bodies. In addition, 
larger axons will respond to lower stimulus intensities than will smaller axons. Also, 
axons with multiple branches will be more easily activated than axons without branching 
processes. 
Other programmable parameters that neurostimulators utilize for neuromodulation include 
voltage, pulse width, cycle on and off times, ramping, duration, and frequency. The 
combination of these parameters is critical for maximum efficacy. For example, both low 
and high frequency stimulation protocols have been attempted for seizure control. 
Historically, low frequency protocols (1 Hz), have been used in neurophysiological 
experiments involving synaptic plasticity and memory. In particular, 1 Hz stimulation in 
many circumstances resulted in so-called, long-term depression (LTD), a molecular correlate 
of memory associated with amnesia and forgetting. Because, LTD also leads to decreases in 
neuronal excitability, it has been postulated that low frequency protocols around 1 Hz 
should be effective in reducing seizure frequency. However, the evidence to date shows 
mixed results in this regard. For example, Weiss et al. demonstrated that the application of 1 
Hz (15 min.) to the hippocampus or amygdala following a so-called kindling stimulus (60 
Hz for 1 sec once daily) produced a long lasting suppressive effect on seizure activity 
(Weiss, Li et al. 1995). However, in a follow-up study by the same lab, it was reported that 
the stimulators that were used in the original study emitted an unexpected low level (i.e., 5 –
15 μA) direct current, which was suspected to have a significant effect on the inhibition on 
seizure activity (Weiss, Eidsath et al. 1998). Substantially more experimental work has 
actually been accomplished to date in both animal models and in human trials using higher 
frequencies of stimulation (ie., around 130 Hz) for seizure control. Overall, frequencies from 
0.1 to 450 Hz have been tried in both animals and humans with various results (Rise 2004; 
Albensi, Oliver et al. 2007). 
One other aspect is worth mentioning. Stimulation can be applied using either open loop 
or closed loop systems (Li and Mogul 2007; Pollo and Villemure 2007). Closed loop is 
defined as the delivery of electric current to a target, exclusively in response to a prompt. 
This type of delivery would be defined by a computer algorithm, whose onset is triggered 
by a seizure detection device.  An example of open loop stimulation would be any 
stimulation protocol that is delivered independently of the time of occurrence between 
seizures. 
Finally, a mention of safety issues is also appropriate. Early attempts in electrical 
stimulation resulted in some deleterious results. For example, repeated applications of 
direct current caused tissue injury, which was reversed if one used charge-balanced 
pulses instead. In other words, a stimulus protocol that utilizes two phases of current flow 
(positive and negative phases) resulting in a net charge flow of zero proved optimal and is 
now the standard method for pulse delivery. Other experimental attempts have resulted 
in the realization that only delivering limited levels of charge density per phase are 
essential so that the overall risk of injuring tissue is minimized. Some infections near the 
site of electrode implantation have also been reported, however, these occurrences are 
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quite low and have not been serious. There are also some concerns when using DBS in a 
MRI context and some cases have been where excessive heating of the implanted 
electrodes has been an issue (Sharan, Rezai et al. 2003; Coffey 2004; Rezai, Phillips et al. 
2004) 
4. Mechanisms of stimulation 
As of this writing, mechanisms for DBS or VNS are not known. Several theories have been 
put forward for nervous system studies involving electrical stimulation in general, and for 
DBS and VNS in particular. For example, some speculate that prolonged electrical 
stimulation “jams” neuronal circuits (Greenberg 2002); however, this explanation is vague 
from a neurophysiological point of view. Slightly more developed theories (Pollo and 
Villemure 2007; Shapiro, Vaillancourt et al. 2007; Montgomery and Gale 2008) have 
proposed mechanisms involving “inhibition of synaptic transmission”, a.k.a. the 
neurochemical hypothesis, or “depolarization blockade”, a.k.a. the electrical hypothesis, but 
substantial evidence is lacking in both regards and these ideas have not yet been thoroughly 
substantiated in experimental models.  
Interestingly, the effects of neurostimulation are known to change with the frequency of 
stimulation and also with the duration of the pulse or train of stimulation. This implies that 
stimulation at any particular target may attenuate seizures with some electrical parameters 
and induce seizures with other parameters. Evidence to date also supports this notion; for 
example, it is well known that kindling protocols (Fisher 1989; Weiss and Post 1998; Albensi, 
Oliver et al. 2007) are used to indirectly induce epilelptiform activity in intact animals.  It 
should also be realized that there may be several mechanisms responsible for efficacy – not 
just one, which makes the investigation of mechanisms more complex than perhaps 
originally thought. 
There is also one other concept that is often brought up when one discusses potential 
mechanisms of action and that is the idea of remote control versus direct control (Pollo and 
Villemure 2007). Central to this idea, electrical stimulation of specific circuits in cortical and 
basal ganglia networks appear to result in different levels of control depending on which 
brain region network is being targeted. In other words, targeting the area of epileptiogenesis 
(ie., seizure focus) with neurostimulation is called direct control. Whereas, electrically 
stimulating one of the intermediate relays or fibers in some circuit that connects to the 
epileptic zone is considered remote control. Examples of remote control include 
neurostimulation of the dorsal midbrain anticonvulsant zone (DMAZ), anterior thalamic 
nuclei, white matter tracts, and the centromedial thalamic nuclei. An example of direct 
control would be electrical stimulation of the hippocampus. Both approaches have shown 
efficacy and are active areas of investigation to determine which approach may be more 
effective. 
5. Recent studies  
Over the last several months promising human data has been published by Fisher et al. 
showing that electrical stimulation of the anterior nucleus of the thalamus reduced seizure 
frequency in individuals with refractory epilepsy (Fisher, Salanova et al. 2010). This ongoing 
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study was prospective, randomized, parallel, and double-blinded in design.  One hundred 
and ten patients were randomized at the start of the trial. Those treated were adults with 
refractory partial seizures, including subjects with secondarily generalized seizures. In this 
study, at least three anti-seizure drugs must have failed to produce seizure control prior to 
baseline in order to be eligible for inclusion. At baseline seizure frequency was 
approximately 19.5%. At the time of this writing the study is over two years old. During 
months 1-4 of the trial, all participants were blinded where one-half received stimulation 
(typically using 145 Hz) and the other one-half received no stimulation. In the last month of 
the blinded phase (ie., month 4) the stimulated group had a 29% greater reduction in 
seizures compared with the control group (p=0.002). By two years, there was a 56% median 
percent reduction in seizure frequency. Interestingly, participants showed no group 
differences in mood or cognition, but those in the stimulated group were more likely to 
report problems with memory or depression. Overall, it was concluded that bilateral 
stimulation of the anterior thalamus was effective at reducing partial and secondarily 
generalized seizures. 
In yet another recent study, a multi-center, prospective, randomized, double-blinded, sham 
controlled trial of individuals 18 to 70 years of age with medically intractable seizures for 3 
months or more and localized to one or two foci is underway (Spencer, Gwinn et al. ; 
Skarpaas and Morrell 2009). In this trial, one-hundred and ninety-one subjects were 
recruited in order to test a cranially implanted programmable responsive neurostimulator 
(NeuroPace, Inc.). This device was used for treating partial onset seizures with or without 
secondary generalization. To be eligible for inclusion, subjects had to have failed 2 or more 
antiepileptic medications. One month following implantation, subjects were randomized 1:1 
to receive sham or active responsive stimulation. In this study, the neurostimulator was 
programmed to acquire data on seizure detection. Stimulation was then delivered at the 
time and site of detection (eg., mesial temporal structures - hippocampus), before seizure 
spread or before any overt symptoms appeared. In other words, the system is designed to 
detect abnormal electrical activity in the brain and to deliver electrical stimulation to 
suppress seizures before there are overt seizure symptoms. Subjects were blinded to their 
treatment for 3 months. During this blinded period, neurostimulation was shown to 
significantly (p=0.012) reduce the number of seizures per day by 37.9% as compared to 17% 
in the untreated arm. After three months of blinded treatment the individuals were allowed 
to continue in the study in an open label manner. Some complications were seen from 
treatment, such as implant site infections and intracranial hemorrhage, but these side effects 
were relatively low in frequency. 
6. Future directions  
The use of neurostimulation for nervous system modulation is rapidly increasing. The 
success of this therapy, however, is far ahead of our understanding of the mechanism(s) 
associated with neurostimulation. It is also important to remember that early success using 
neurostimulation techniques occurred with technology that was not specifically fabricated 
for the current applications. In other words, only recently have the medical devices used for 
neurostimulation been designed and tailored for their present use and so it is possible the 
field may soon witness unprecedented growth given improved technology in the future.  
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One past limiting factor has been the ability to predict and detect seizure onset. Much work 
is still needed in this regard, but some very recent advances have been made (see discussion 
above concerning the NeuroPace trial). How to determine when a seizure will begin remains 
one of the great unanswered questions in epilepsy. Without a doubt, this limitation is a 
serious one, but once overcome, we will greatly advance the implementation of technology 
for responsive forms of neurostimulation. Advances in signal processing and detection 
devices will most certainly help in this regard. 
It should also be noted that other technologies are being developed in parallel and may 
profoundly influence the field of neuromodulation therapy in epilepsy and other CNS 
disorders. For example, transcranial magnetic stimulation is also under development and 
has been shown to noninvasively interfere with neural activity. In particular, low frequency 
repetitive transcranial magnetic stimulation appears to temporarily improve intractable 
epilepsy. At this time, it is hard to predict if and how this technology may or may not 
advance in unison with techniques that involve the chronic implantation of electrodes. 
From a neurobiological point of view it is hard to believe that repetitive stimulation has no 
effect on the genome. The truth is we do not know if it does or does not and to date very 
little research has been accomplished to explore this possibility. Future studies are 
warranted that would profile gene expression at various frequencies and other conditions to 
determine the long term effects of electrical stimulation on cell physiology. 
Interestingly, attempts at using DBS in obesity have resulted in some unexpected results. In a 
recent study by Lozano et al. (Hamani, McAndrews et al. 2008), physicians were attempting to 
treat a morbidly obese man using DBS and found that electrical stimulation of the 
hypothalamus/fornix caused the patient to experience vivid memories. The individual 
suffered from type 2 diabetes and also sleeping disorders and failed to respond to other forms 
of treatment for these conditions.  DBS for treating obesity is very new and only a few attempts 
have been made in this regard. Following surgery the patient recovered for two months, and 
later when the implanted electrodes were stimulated once again, he experienced the 
recollection of more memories. These results suggest that DBS might be a viable alternative for 
those with memory disorders; in particular, for those with Alzheimer’s disease (AD). To this 
end, Lozano and colleagues are currently conducting a pilot study in AD patients (Laxton, 
Tang-Wai et al.) where 6 patients are being treated with this therapy. Data from this study 
suggested that DBS treatment in hippocampal areas resulted in an early and striking reversal 
of impaired glucose utilization in temporal and parietal lobes (as measured by PET scans) that 
was maintained after 12 months of continuous stimulation. These data are so new and 
unexpected and the sample sizes are so low, that it is important to add a note of caution in 
association with these studies. Regardless of the studies’ limitations, further work is warranted 
to investigate these very preliminary, but exciting findings. 
It is also expected that scientists and physicians from a variety of disciplines, such as 
bioengineering, computer science, neurophysiology, neurology, and psychiatry, etc. will 
work together more cohesively than in the past in order to advance the field of 
neurostimulation; this will be important with regard to understanding mechanisms of 
action, advancing technology, and improving the quality of life of epilepsy patients and 
others with serious CNS disorders. 
In any case, it should be obvious that we are witnessing a new horizon with promising 
results thus far and unimaginable rewards and outcomes yet to come. 
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Target 
Stimulated 
Proposed Pathway and/or 
Mechanism 
Efficacy 
Cerebellum Direct anterograde cortical 
inhibition or stimulation 
Significant seizure reduction in 
uncontrolled human studies, but no 
significant change in controlled human 
trials (Walker 1938; Moruzzi and Magoun 
1949; Cooper, Upton et al. 1982) 
Caudate Direct anterograde cortical 
stimulation 
Significant seizure reduction in 
uncontrolled human studies (Sramka, Fritz 
et al. 1976; Chkhenkeli 1978) 
Posterior 
hypothalamus 
Direct anterograde cortical 
stimulation 
Significant increase in seizure threshold in 
pentylenetetrazol (PTZ) rat model (Mirski 
and Fisher 1994) 
Anterior 
thalamic 
nucleus 
Direct anterograde cortical 
stimulation 
One uncontrolled human study showing 
seizure reduction in 3 out of 5 patients 
(Cooper, Upton et al. 1980) 
Centromedian 
thalamic 
nucleus 
Direct anterograde cortical 
stimulation 
Significant seizure reduction in 
uncontrolled human trials, but no 
significant change in controlled human 
trials (Velasco, Velasco et al. 1987) 
Subthalmic 
nucleus 
Nigral control of epilepsy 
system or antidromic 
cortical stimulation 
Significant seizure reduction in 
uncontrolled human trials, but no 
controlled human trials performed 
(Vercueil, Benazzouz et al. 1998; Benabid, 
Minotti et al. 2002) 
Cortical 
stimulation 
Direct stimulation of 
epileptogenic focus 
Brief bursts of pulse stimulation reported to 
terminate afterdischarges caused by cortical 
stimulation (Lesser, Kim et al. 1999; Luders, 
Najm et al. 2004) 
Hippocampal 
stimulation 
Direct stimulation of 
epileptogenic focus 
Significant seizure reduction rats and in 
uncontrolled and controlled human studies 
(Velasco, Velasco et al. 2000; Albensi, Ata et 
al. 2004; Velasco, Velasco et al. 2007; 
Albensi, Toupin et al. 2008) 
Vagal nerve 
stimulation 
Direct anterograde cortical 
stimulation via activation of 
thalamic, brainstem, and 
limbic structures 
Significant seizure reduction in rats and 
controlled human trials (Penry and Dean 
1990; Woodbury and Woodbury 1990) 
Trigeminal 
nerve 
stimulation 
Direct anterograde cortical 
stimulation via 
desychronization of cortical 
and thalamic structures 
Significant seizure reduction in rats, but no 
human studies to date (Fanselow, Reid et al. 
2000) 
White matter 
tract 
stimulation 
Direct anterograde and 
retrograde stimulation of 
epileptogenic focus 
Significant seizure reduction in rats, but no 
human studies to date (Luders, Najm et al. 
2004) 
*Modified from, Luders et al., (Luders, Najm et al. 2004) 
Table 1. Summary of Electrical Stimulation Studies in Epilepsy in Humans and Animal 
Models* 
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